SMS Lifesciences Reports Mixed Financial Results Amid Improved Efficiency Metrics in June 2025

SMS Lifesciences India, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results indicate a notable shift in the company's evaluation, with the score adjusting to -10 from -12 over the past three months.
Several factors are contributing positively to SMS Lifesciences' performance. The inventory turnover ratio has reached a high of 5.11 times on a half-yearly basis, demonstrating the company's efficiency in selling its inventory more rapidly. Additionally, the debt-equity ratio stands at its lowest in the last five half-yearly periods at 0.44 times, reflecting a strategic reduction in borrowing relative to equity capital.

Conversely, the financial results also highlight areas of concern. Profit Before Tax (PBT) has reported a decline of 40.98% year on year, amounting to Rs 6.02 crore. Similarly, Profit After Tax (PAT) has decreased by 40.6% year on year, totaling Rs 4.16 crore. Furthermore, net sales have fallen by 10.86% year on year, reaching Rs 82.50 crore. These trends suggest challenges in maintaining revenue and profitability levels.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.